Wikipedia

User:BexarTech/Kinetic Concepts draft

< User:BexarTech
Kinetic Concepts, Inc.
Company typePublic (NYSE: KCI)
IndustryMedical devices, Medical technology
FoundedSan Antonio, Texas, USA by Jim Leininger,1976
Headquarters
San Antonio, Texas
,
USA
Key people
Catherine M. Burzik, President and CEO
Ronald W. Dollens, Chairman of the Board
ProductsV.A.C. Freedom® Therapy System, InfoV.A.C.® Therapy System, V.A.C. ATS®Therapy System, ActiV.A.C.® Therapy System, Prevena™ Incision Management System, ABThera™ Open Abdomen Negative Pressure System, Strattice® Reconstructive Tissue Matrix, AlloDerm® Regenerative Tissue Matrix, RotoProne Therapy System™, BariMaxx™ II Therapy System, Spirit Select™ Bed and AtmosAir™ 9000 Mattress Replacement System, Skin IQ™ Microclimate Manager[1]
RevenueUS$2.02 billion Increase (2010)
US$256.1 million Increase (2010)
Number of employees
6,800 (2010)
Websitewww.kci-medical.com

Kinetic Concepts, Inc. (NYSE: KCI), (KCI) is an American based multinational medical technology company with headquarters in San Antonio, Texas. The company develops and markets a range of high-technology therapies, including therapeutic beds, wound care and tissue regeneration technology. KCI produced the first product developed specifically for negative pressure wound therapy, V.A.C. Therapy. As of 2010 the company employs 6,800 people and markets its products in more than 20 countries.[2]

Operations edit

KCI is composed of three business units: Active Healing Solutions, LifeCell and Therapeutic Support Systems, that operate in the wound care, regenerative medicine and therapeutic support systems markets.[3][4] The largest of these business units is the KCI Active Healing Solutions division which markets wound care products[5] that deliver negative pressure to promote wound healing and/or address a variety of surgical challenges. In particular, KCI specializes in vacuum-assisted closure (V.A.C.) technology.[6] The company develops and supplies a range of products for use in wound healing under the brand V.A.C. Therapy. The V.A.C. Therapy products are for use in treating a wide range of wounds including traumatic wounds, pressure ulcers, chronic wounds and diabetic ulcers.[7] The therapeutic support systems developed and supplied by KCI are largely for the treatment and prevention of complications associated with patient immobility.[8] These include support surfaces for hospital beds and home patients designed to address pulmonary complications in immobile patients. KCI also develops specialty beds for use in hospitals or in long-term care facilities.[9] The latest addition to KCI's business is regenerative medicine, into which the company expanded in 2008.[3] Through subsidiary company LifeCell Corporation, KCI develops and supplies tissue-based products. These include tissue-based treatments used in surgical procedures to repair soft-tissue.[10]

KCI products are used in hospitals, long-term care facilities[9] and also by the US military.[11] For Active Healing Solutions and Therapeutic Support Systems' products, KCI's development process includes what it calls Highly Accelerated Life Testing. This testing is carried out by using high levels of shaking and vibration, among other techniques, in order to ensure the products are durable. In addition, KCI carries out training in the use of V.A.C. Therapy for almost 50,000 clinicians each year.[12]

Corporate history edit

KCI was founded in 1976 in San Antonio, Texas by Dr. Jim Leininger, an emergency room physician[8] who wanted to help prevent the pulmonary complications associated with immobility. In time the company developed or acquired a line of therapeutic specialty beds, surfaces and related devices including, the TriaDyne Critical Care Therapy System. This was introduced in 1995 as a specialty bed for acute care patients with pulmonary complications.[13] Initially KCI's product development focused on therapeutic beds and surfaces, however, in the mid-1990s the company introduced V.A.C. Therapy, the first commercial negative pressure wound therapy (NPWT) technology.[14][6] KCI expanded into regenerative medicine in 2008 when the company purchased LifeCell Corporation, a developer of tissue regeneration products.[3]


Company financial information edit

From the founding of the company in 1976 to 1988, the revenue of KCI grew to US$153.2 million. The growth in revenue allowed KCI to go public and trade on the New York Stock Exchange (NYSE) in 1988.[15] KCI stock was traded on the NYSE until 1997, when the company went private. In February of 2004, KCI became a publicly listed company for the second time and is since listed on the NYSE under the ticker symbol KCI.[6][16] By the late 2000s the company's revenue was over $1 billion and reported an increase of 17 percent in 2007 to $1.61 billion.[17] Revenue for 2008 was $1.88 billion, increasing to $1.99 billion in 2009[18] and in 2010 increased to $2.02 billion.[19]

Negative pressure wound therapy edit

KCI first marketed its V.A.C. Therapy System in 1995. The V.A.C. Therapy System comprises a foam dressing placed into the wound, followed by covering the wound with a transparent dressing; tubing then connects the dressing to a vacuum pump that applies negative pressure, sealing the wound.[11] Studies published in 1997 demonstrated the use of V.A.C. Therapy in wound treatment and found that V.A.C. Therapy led to increased formation of granulation tissue.[20][21] The V.A.C. Therapy System is intended to help promote wound healing; clinical studies have shown that it has the potential to decrease length of stay and incidence of complications, compared to standard of care wound therapy, through its unique mechanisms of action.[22][23][24][25] In the US KCI V.A.C. Therapy products have been given reimbursement approval under Medicare and Medicaid, and are also covered by many private insurers.[6] Since the launch of the first V.A.C. Therapy product in 1995, KCI has developed a range of V.A.C. Therapy products including specialized dressings and portable units such as the V.A.C. Via Therapy System.[22][26] KCI trains nearly 50,000 clinicians per year to use the V.A.C. Therapy products for wound treatment.[12]

KCI V.A.C. Therapy units may be used in the home, as well as in acute care settings.[27][28] In 2010, the FDA launched a Medical Device Home Use Initiative, intended to improve the safety of medical devices used by patients at home or in care facilities. KCI has stated that it supports this initiative and plans to improve home use safety.[29] KCI V.A.C. Therapy products for use in the home have "undergone extensive scrutiny" to ensure their safety and appropriateness for use by patients and caregivers who may not have clinical backgrounds, according to Mike Genau, global president of KCI's 'Active Healing Solutions' division. In addition, KCI has provided a telephone support line that patients can call to speak to technical representatives or clinicians 24 hours a day.[12]

One of KCI's NPWT products, the V.A.C. Freedom Therapy System was awarded with the US Army and US Air Force's Joint Airworthiness Certification in December 2006, and is the only NPWT product used in military aeromedical evacuation. The US military also uses V.A.C. Therapy products for wound treatment in its military hospitals and in combat zones.[2]

LifeCell Corporation edit

LifeCell Corporation, a regenerative medicine company, has developed a range of tissue-based products for use in reconstructive surgery and tissue-regeneration and is one of the leading providers of biological products used in soft-tissue repair. Its products include a reconstructive tissue matrix called Strattice Reconstructive Tissue Matrix, intended for use in surgical procedures including plastic reconstructive surgery and abdominal wall reconstruction, and AlloDerm Regenerative Tissue Matrix, a regenerative tissue product used in surgical procedures for challenging hernia repair, breast reconstruction post mastectomy and for periodontal procedures.[30]

KCI made an agreement in April 2008 to purchase LifeCell in a non-hostile transaction for US$1.7 billion.[30][31] LifeCell's CEO is Lisa Colleran, who took on the role in August 2008 following the acquisition by KCI.[32]

See also edit

References edit

  1. ^ "Products". KCI1.com. Retrieved 17 March 2011.
  2. ^ a b "FDA clears new KCI abdominal wound-care product". San Antonio Business Journal. 19 May 2009. Retrieved 25 January 2011. Cite error: The named reference "SanAntonio" was defined multiple times with different content (see the help page).
  3. ^ a b c "KCI earnings up during second quarter". San Antonio Business Journal. 21 July 2009. Retrieved 25 January 2011.
  4. ^ "Kinetic Concepts and Carroll Hospital Group form partnership". Datamonitor NewsWire. 6 April 2009.
  5. ^ "KCI Appoints Kien Nguyen Vice President of Global Marketing for Active Healing Solutions(TM)". Business Wire. 21 April 2010.
  6. ^ a b c d Benesh, Peter (14 June 2004). "Second IPO Helps Heal Old Wounds; Kinetic Concepts Inc.; San Antonio, Texas". Investor's Business Daily. p. A09. {{cite news}}: More than one of |at= and |page= specified (help)
  7. ^ "vacuum Assisted Closure Wound Therapy Cleared for Partial Thickness Burns". Reuters Health Medical News. 27 January 2003.
  8. ^ a b "Kinetic Concepts Inc. Implements SolidWorks Software as Company-Wide Engineering Standard". Business Wire. 6 March 2000.
  9. ^ a b "Kinetic Concepts Acquires RIK Medical". PR Newswire. 6 October 1997.
  10. ^ "Kinetic Concepts now owns LifeCell Corp". Biomedical Materials: 5. 1 July 2008. ISSN 0955-7717.
  11. ^ a b "Kinetic Concepts: High-Tech Healing". Bloomberg Businessweek. 4 June 2007. Retrieved 25 January 2011.
  12. ^ a b c Mike Genau (1 September 2010). "Shift toward home care requires labeling, and design changes". Medical Design.
  13. ^ "Kinetic Concepts introduces TriaDyne(TM), latest addition to line of therapeutic beds and surfaces". Business Wire. 23 May 1995.
  14. ^ "KCI Honors Dr. Louis Argenta With Research-Based Fellowship and Scholarship". Business Wire. 12 October 2009.
  15. ^ Blaker, Ashley (24 December 1990). "Kinetic Expands Foreign Presence With Acquisitions". San Antonio Business Journal. 4 (49): 1.
  16. ^ Berko, Malcolm (3 August 2007). "Wound-care developer is a healthy company". Copley News Service.
  17. ^ "KCI concludes 2007 on strong note". San Antonio Business Journal. 29 January 2008.
  18. ^ "Highlights KCI". MSN Money. MSN. January 2011. Retrieved 25 January 2011.
  19. ^ "Kinetic Concepts 4Q profit grows 12 percent". Bloomberg Business News. Associated Press. 1 February 2011. Retrieved 4 February 2011.
  20. ^ Argenta, Louis; Morkywas, Michael (June 1997). "Vacuum-assisted closure: a new method for wound control and treatment: clinical experience". Annals of Plastic Surgery. 38 (6): 563–76. doi:10.1097/00000637-199706000-00002. PMID 9188971. Retrieved 25 January 2011.{{cite journal}}: CS1 maint: date and year (link)
  21. ^ Argenta, Louis; Morkywas, Michael; Shelton-Brown, E; McGuirt, W (June 1997). "vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation". Annals of Plastic Surgery. 38 (6): 553–62. doi:10.1097/00000637-199706000-00001. PMID 9188970. Retrieved 25 January 2011.{{cite journal}}: CS1 maint: date and year (link)
  22. ^ a b "KCI to Launch V.A.C.Via™, an Advanced Mobile Healing Technology". Business Wire.com. 26 April 2010. Retrieved 25 January 2011.
  23. ^ Augustin, M; Zshocke, I (2006). "Nutzenbewertung der ambulanten und stationären V.A.C.-Therapie aus Patientensicht". MMW-Fortschritte der Medizin Originalien (in German). 148 (1): 25–32.
  24. ^ Armstrong, DG; Lavery, LA (2005). "Negative Pressure Wound Therapy After Partial Diabetic Foot Amputation: A Multicentre Randomised Controlled Trial". Lancet. 366 (9498): 1704–10. doi:10.1016/S0140-6736(05)67695-7. PMID 16291063. Retrieved 25 January 2011.
  25. ^ Philbeck, TE; Schroeder, WJ; Whittington, KT (2001). "Vacuum-assisted closure therapy for diabetic foot ulcers: clinical and cost analysis". Home Health Care Consultant. 8 (3): 26–34.
  26. ^ Danner, Patrick (17 January 2011). "KCI launches product to treat pressure ulcers". MySanAntonio.com. Retrieved 25 January 2011.
  27. ^ "FDA Medical Device Database". FDA.gov. U.S. Department of Health and Human Services. Retrieved 17 March 2011.
  28. ^ "KCI Announces US Food and Drug Administration Clearance for Next-Generation V.A.C.(R) Therapy Technologies Across Multiple Care Settings Including Home Use". Sales and Marketing Network.com. The Healthcare Sales and Marketing Network. 11 June 2007. Retrieved 25 January 2011.
  29. ^ Nathaniel Weixel (14 July 2010). "Industry Supports Home Use Initiative, Cautions Against Burdensome Regulations". BNA.
  30. ^ a b "KCI to Acquire LifeCell for $1.7 Billion in Cash Creating a Global Medical Technology Leader". Business Wire. 7 April 2008.
  31. ^ "Analyst questions Kinetic Concepts' purchase of LifeCell due to high price and low revenue". The Associated Press. 8 April 2008.
  32. ^ "Executive Profile: Lisa N. Colleran". Bloomberg Businessweek. Retrieved 4 February 2011.

External links edit

[[Category:Multinational companies]] [[Category:Companies based in San Antonio, Texas]] [[Category:Companies established in 1976]] [[Category:Pharmaceutical companies of the United States]]

Retrieved from "https://en.wikipedia.org/w/index.php?title=User:BexarTech/Kinetic_Concepts_draft&oldid=1168384900"